5 Year Efficacy and Biomarker Data for Axitinib/Pembrolizumab in 1st Line Clear Cell RCC

Retrieved on: 2025-08-02 17:30:50

Tags for this article:

Click the tags to see associated articles and topics

5 Year Efficacy and Biomarker Data for Axitinib/Pembrolizumab in 1st Line Clear Cell RCC. View article details on hiswai:

Excerpt

Tom Powles: 5 Year Efficacy and Biomarker Data for Axitinib/Pembrolizumab in 1st Line Clear Cell RCC / axitinib, cancer, OncoDaily, Oncology, ...

Article found on: oncodaily.com